Agilent cancer treatment approved in Europe
Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →
Read More →Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira
The European Medicines Agency recommended the approval of the ABP 501, a biosimilar of AbbVie’s Humira (adalimumab), for treatment of inflammatory diseases, Thousand Oaks-based biotech company Amgen announced on Jan. 27. The EMA recommended ABP 501’s use for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate-to-severe Read More →
Read More →Cynvenio inks deal with Milenia Labs to distribute blood test
Westlake Village cancer treatment company Cynvenio Biosystems announced an exclusive agreement with diagnostic test company Milenia Labs to distribute a blood test for breast cancer at its 12 diagnostic centers in Mexico. Financial details of the deal were not disclosed. The test provides real-time information about cancer cell activity for patients who have completed treatment Read More →
Read More →Digital West completes merger with Norcast Telecom
Digital West announced Jan. 24 that it completed a merger with its fellow IT network provider Norcast Telecom, both headquartered in San Luis Obispo. Together, they will have 60 employees with no staff reductions planned. “Our two companies have worked closely for more than 10 years; in fact, we work with many of the same Read More →
Read More →Lockheed Martin reports strong fourth quarter earnings
Defense and technology giant Lockheed Martin, which has operations in Goleta, reported earnings of $3.25 per share for the fourth quarter of 2016, bringing it up to $12.38 per share for the year. Sales grew from $11.8 billion in the final quarter of 2015 to $13.8 billion, the company reported Jan. 24, with net earnings Read More →
Read More →